|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 20 |
| 2 | 曲妥珠单抗联合化疗与单纯化疗治疗HER2阳性晚期胃或胃食管结合部癌的Ⅲ期、开放、随机对照临床试验(ToGA试验)显示文摘 | Van Cutsem E Feyereislova A 张信华 | 2010 | 消化肿瘤杂志(电子版)2010，，03： | 12 |
| 3 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet . 2010 (9742)2010，，9742： | 6 |
| 4 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 2 |
| 5 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | 2010 (9742)2010，，9742： | 2 |
| 6 | Trastuzurnab in com bination with chemotherapy versus chemotherapy alone for treatment of Her-2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 3, open-label, randomised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 7 | 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial显示文摘 | Ian Smith Marion Procter Richard D Gelber Sébastien Guillaume Andrea Feyereislova Mitch Dowsett Aron Goldhirsch Michael Untch Gabriella Mariani Jose Baselga Manfred Kaufmann David Cameron Richard Bell Jonas Bergh Robert Coleman Andrew Wardley Nadia Harbec | 2007 | The Lancet2007，，9555： | 1 |
| 8 | Trastuzumab in combination with chemotherapy versuschemotherapy alone for treatment of HER2 - positive advancedgastric or gastro - oesophageal junction cancer(ToGA) : A phase 3, open - label, randomised controlledtrial 显示文摘 | BANGYJ VAN CUTSEM E FEYEREISLOVA A | | Lancet0，2010，376： | 1 |
| 9 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (TOGA) : a phase3, open-label, randomised con- trolled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，： | 1 |
| 10 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 1 |
| 11 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesoph- ageal junction cancer (TOGA): a phase 3, open-label, ran- domised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 12 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (To- GA): a phase 3, open-label, randomised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 13 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2- positive advanced gastricor gastro- oesophageal junctioncancer (TOGA): a phase 3, open-label, randomised controlled trial 显示文摘 | Bang YJ Cntsem EV Feyereislova A | 2010 | The Lancet2010，376，9742： | 1 |
| 14 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oe- sophageal junction cancer( ToGA ) : a phase 3, open-label ran- domized controlled trial显示文摘 | Bang Y-J Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 15 | Trastuzumab in combi-nation with chemotherapy versus chemotherapy alone for treatment ofHER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA) :a phase 3,open-label,randomised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lan-cet2010，376，9742： | 1 |
| 16 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophage-al junction cancer (ToGA) : a phsae 3,open-label, randomised controlled trial显示文摘 | Bang YJ Van Custsem EV Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 17 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 1 |
| 18 | Trastuzumab in combi- nation with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 3, open-label, randomised controlled trial 显示文摘 | Bang Y J Van Cutsem E Feyereislova A | 2010 | The Lancet2010，376，9742： | 1 |
| 19 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):a phase3,open-label,randomised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | | 0，，9742： | 1 |
| 20 | Trastuzumab incombination with chemotherapy versus chemotherapy alone fortreatment of HER-2-positive advanced gastric or gastro-oesophagealjunction cancer (ToGA ) : a phase 3,open-label, randomised con-trolled trial显示文摘 | Bang Y J Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员